LABP
Landos Biopharma, Inc. Common Stock
LABP
LABP
Delisted
LABP was delisted on the 23rd of May, 2024.
33 hedge funds and large institutions have $261M invested in Landos Biopharma, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
33
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.91M | |
| 2 | +$1.35M | |
| 3 | +$500K | |
| 4 |
BlackRock
New York
|
+$436K |
| 5 |
AI
ArchPoint Investors
Coral Gables,
Florida
|
+$292K |
Top Sellers
| 1 | -$4.33M | |
| 2 | -$879K | |
| 3 | -$868K | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$674K |
| 5 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$511K |